Search results
- 1.0191506 - UMG-J 20023088 RIV US eng J - Journal Article
Plášilová, M. - Živná, J. - Jelínek, J. - Neuwirtová, R. - Čermák, J. - Nečas, E. - Anděra, Ladislav - Stopka, T.
TRAIL (Apo2L) supresses growth of primary human leukemia and myelodysplasia progenitors.
Leukemia. Roč. 16, č. 1 (2002), s. 67-73. ISSN 0887-6924. E-ISSN 1476-5551
R&D Projects: GA AV ČR IAA5052001; GA ČR GA301/99/0350
Keywords : TRAIL * leukemia * myelodysplasia
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 4.693, year: 2002
Permanent Link: http://hdl.handle.net/11104/0087257 - 2.0191505 - UMG-J 20023087 RIV US eng J - Journal Article
Weber, T. - Lu, M. - Anděra, Ladislav - Lanm, H. - Gellert, N. - Fariss, M. W. - Kořínek, Vladimír - Sattler, W. - Ucker, D. S. - Terman, A. - Schroder, B. - Erl, W. - Brunk, U. T. - Coffey, R. J. - Weber, C. - Neužil, J.
Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo.
Clinical Cancer Research. Roč. 8, č. 3 (2002), s. 863-869. ISSN 1078-0432. E-ISSN 1557-3265
R&D Projects: GA AV ČR IAA5052001; GA ČR GA301/99/0350
Keywords : Vitamin E * TRAIL * apoptosis
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 5.991, year: 2002
Permanent Link: http://hdl.handle.net/11104/0087256 - 3.0191428 - UMG-J 20010500 RIV GB eng J - Journal Article
Plašilová, M. - Živný, J. - Jelínek, J. - Neuwirtová, R. - Čermák, J. - Nečas, E. - Anděra, Ladislav - Stopka, T.
TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors.
Leukemia. Roč. 16, č. 1 (2002), s. 67-73. ISSN 0887-6924. E-ISSN 1476-5551
R&D Projects: GA AV ČR IAA5052001; GA ČR GA301/99/0350
Institutional research plan: CEZ:AV0Z5052915
Keywords : TRAIL * leukemia * apoptosis
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 4.693, year: 2002
Permanent Link: http://hdl.handle.net/11104/0087181 - 4.0191427 - UMG-J 20010499 RIV US eng J - Journal Article
Plašilová, M. - Živný, J. - Jelínek, J. - Neuwirtová, R. - Čermák, J. - Nečas, E. - Anděra, Ladislav - Stopka, T.
TRAIL/APO2L inhibits myelodysplasia and myeloid leukemia progenitor growth while it does not affect normal progenitors in vitro and normal CD3+ cell repopulation in NOD/SCID mice.
Blood. Roč. 98, č. 11 (2001), s. 3043. ISSN 0006-4971. E-ISSN 1528-0020
R&D Projects: GA AV ČR IAA5052001
Institutional research plan: CEZ:AV0Z5052915
Keywords : TRAIL * leukemia * apoptosis
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 9.273, year: 2001
Permanent Link: http://hdl.handle.net/11104/0087180 - 5.0105320 - UMG-J 20043110 RIV US eng J - Journal Article
Tomasetti, M. - Rippo, M. R. - Alleva, R. - Moretti, S. - Anděra, Ladislav - Neuzil, J. - Procopio, A.
Alpha-tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells.
[Alfa-tokoferyl sukcinát a TRAIL selektivně spolupůsobí při vyvolání apoptózy u lidských buněk maligního mezoteliomu.]
British Journal of Cancer. Roč. 90, - (2004), s. 1644-1653. ISSN 0007-0920. E-ISSN 1532-1827
R&D Projects: GA MŠMT LN00A026; GA AV ČR IAA5052001
Institutional research plan: CEZ:AV0Z5052915
Keywords : TRAiL, a-TOS, apoptosis
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 3.742, year: 2004
Permanent Link: http://hdl.handle.net/11104/0012563 - 6.0047784 - ÚMG 2007 RIV NL eng J - Journal Article
Tomasetti, M. - Anděra, Ladislav - Alleva, R. - Borghi, B. - Neužil, Jiří - Procopio, A.
Alpha-tocopheryl succinate induces DR4 and DR5 expression by a p53-dependent route: implication for sensitisation of resistant cancer cells to TRAIL apoptosis.
[Alfa-tokoferol sukcinát vyvolává expresi DR4 a DR5 cestou závislou na p53: implikace pro sensitizaci rezistentních nádorových buněk k apoptóze vyvolané prostřednictvím TRAIL.]
FEBS Letters. Roč. 580, č. 8 (2006), s. 1925-1931. ISSN 0014-5793. E-ISSN 1873-3468
R&D Projects: GA AV ČR(CZ) IAA5052001; GA MŠMT(CZ) LN00A026
Institutional research plan: CEZ:AV0Z50520514
Keywords : malignant mesothelioma * TRAIL * alpha-TOS
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 3.372, year: 2006
Permanent Link: http://hdl.handle.net/11104/0138589